ARYZTA (ARYN) Q3 2025 TU earnings summary

Executive summary

• Q3 organic growth reached 0.8%, with positive pricing offsetting flat volumes against strong prior-year comparables.

• Year-to-date organic growth stands at 2.1%, supported by both volume/mix and pricing contributions.

• Innovation contributed 18% of revenue year-to-date, with new capacity investments in Malaysia, Switzerland, Germany, and Australia.

• Cost optimisation programmes are being accelerated to address higher-than-expected labour and input cost inflation.

• Leadership reiterates confidence in achieving mid-term targets for 2028, emphasizing operational efficiency and margin progression.

Financial highlights

• Q3 revenue was €554.3m, up 0.4% year-over-year, with Europe contributing €492.8m and Rest of World €61.5m.

• Nine-month group revenue reached €1,640.7m, a 2.1% increase year-over-year.

• Q3 organic growth: Europe 0.7%, Rest of World 1.4%, Group 0.8%.

• Nine-month organic growth: Europe 2.2%, Rest of World 1.8%, Group 2.1%.

• Procurement initiatives delivered over €36 million in cumulative cost optimization from 2022 to 2024.

Outlook and guidance

• Full-year 2025 guidance confirmed: organic growth in the low to mid-single-digit range, EBITDA at least €300 million, and free cash flow around €100 million.

• Mid-term targets (FY2025-28F) confirmed: revenue growth above market, EBITDA margin >15%, EBIT margin >9%, CAPEX at 3.5-4.5% of revenue, and net debt leverage at 1.5-2x.

• Acceleration of cost optimization measures is expected to ensure a swift rebound in profitability and support the path to 2028 margin targets.

• Details on capital return to shareholders will be provided in 2026.